- 1.
Building health systems resilience for universal health coverage and health security during the COVID-19 pandemic and beyond. Geneva: World Health Organization; 2021.
- 2.
- 3.
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations: Geneva; World Health Organization; 2016. [
PubMed: 27559558]
- 4.
Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva: World Health Organization; 2016. Contract No: WHO/HIV/2016.06.
- 5.
Global health sector strategy on sexually transmitted infections, 2016–2021. Geneva: World Health Organization; 2016.
- 6.
Singer
M, Clair
S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. 2003;17(4):423–41. [
PubMed: 14716917]
- 7.
Maheu-Giroux
M, Vesga
JF, Diabaté
S, Alary
M, Baral
S, Diouf
D, et al. Changing dynamics of HIV transmission in Côte d’Ivoire: modeling who acquired and transmitted infections and estimating the impact of past HIV interventions (1976–2015). J Acquir Immune Defic Syndr. 2017;75(5):517–27. [
PMC free article: PMC5508974] [
PubMed: 28471837]
- 8.
Mukandavire
C, Walker
J, Schwartz
S, Boily
MC, Danon
L, Lyons
C, et al. Estimating the contribution of key populations towards the spread of HIV in Dakar, Senegal. J Int AIDS Soc. 2018;21(5):e25126. [
PMC free article: PMC6055131] [
PubMed: 30033604]
- 9.
Stone
J, Mukandavire
C, Boily
MC, Fraser
H, Mishra
S, Schwartz
S, et al. Estimating the contribution of key populations towards HIV transmission in South Africa. J Int AIDS Soc. 2021;24(1):e25650. [
PMC free article: PMC7855076] [
PubMed: 33533115]
- 10.
Grebely
J, Larney
S, Peacock
A, Colledge
S, Leung
J, Hickman
M, et al. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction. 2019;114(1):150–66. [
PMC free article: PMC6657799] [
PubMed: 30035835]
- 11.
Dolan
K, Wirtz
AL, Moazen
B, Ndeffo-Mbah
M, Galvani
A, Kinner
SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102. [
PubMed: 27427453]
- 12.
Jin
F, Dore
GJ, Matthews
G, Luhmann
N, Macdonald
V, Bajis
S, et al. Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(1):39–56. [
PubMed: 33217341]
- 13.
Heffernan
A, Cooke
GS, Nayagam
S, Thursz
M, Hallett
TB. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. Lancet. 2019;393(10178):1319–29. [
PMC free article: PMC6484702] [
PubMed: 30704789]
- 14.
Martin
NK, Vickerman
P, Dore
GJ, Hickman
M. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention. Current opinion in HIV and AIDS. 2015;10(5):374–80. [
PMC free article: PMC4659815] [
PubMed: 26248124]
- 15.
Pitcher
AB, Borquez
A, Skaathun
B, Martin
NK. Mathematical modeling of hepatitis C virus (HCV) prevention among people who inject drugs: a review of the literature and insights for elimination strategies. J Theor Biol. 2019;481:194–201. [
PMC free article: PMC6522340] [
PubMed: 30452959]
- 16.
Platt
L, Minozzi
S, Reed
J, Vickerman
P, Hagan
H, French
C, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9(9):Cd012021. [
PMC free article: PMC5621373] [
PubMed: 28922449]
- 17.
Falla
AM, Hofstraat
SHI, Duffell
E, Hahné
SJM, Tavoschi
L, Veldhuijzen
IK. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC Infect Dis. 2018;18(1):1–12. [
PMC free article: PMC5809955] [
PubMed: 29433454]
- 18.
Miranda
NT, de Souza
RL, Monteiro
JC, Costa
IB, Siravenha
LQ, da Luz
AL, et al. Seroprevalence of HBV and HCV in female sex workers from four cities in the state of Para, northern Brazil. J Med Virol. 2021;93(6):3730–7. [
PubMed: 33368401]
- 19.
Adeyemi
OA, Mitchell
A, Shutt
A, Crowell
TA, Ndembi
N, Kokogho
A, et al. Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria. BMC Infect Dis. 2021;21(1):1–8. [
PMC free article: PMC8259010] [
PubMed: 34229613]
- 20.
Moradi, Ghobad, Marzieh
Soheili, Roya
Rashti, Hojat
Dehghanbanadaki, Elham
Nouri, Farima
Zakaryaei, Elnaz Ezzati
Amini, Sheno
Baiezeedi, Sanaz
Ahmadi, and Yousef
Moradi. “The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis.” European Journal of Medical Research
27, no. 1 (2022): 1–11. [
PMC free article: PMC8962539] [
PubMed: 35346371]
- 21.
Stockdale
AJ, Kreuels
B, Henrion
MY, Giorgi
E, Kyomuhangi
I, de Martel
C, et al. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J Hepatol. 2020;73(3):523–32. [
PMC free article: PMC7438974] [
PubMed: 32335166]
- 22.
- 23.
Bruni
L, Diaz
M, Castellsagué
X, Ferrer
E, Bosch
X, de Sanjosé
S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–99. [
PubMed: 21067372]
- 24.
Forman
D, de Martel
C, Lacey
CJ, Soerjomataram
I, Lortet-Tieulent
J, Bruni
L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(5):F12–23. [
PubMed: 23199955]
- 25.
James
C, Harfouche
M, Welton
NJ, Turner
KM, Abu-Raddad
LJ, Gottlieb
SL, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315–29. [
PMC free article: PMC7265941] [
PubMed: 32514197]
- 26.
Poteat
T, White
RH, Footer
KHA, Park
JN, Galai
N, Huettner
S, et al. Characterising HIV and STIs among transgender female sex workers: a longitudinal analysis. Sex Transm Infect. 2021;97(3):226–31. [
PMC free article: PMC7769682] [
PubMed: 32366602]
- 27.
McLaughlin
MM, Chow
EP, Wang
C, Yang
LG, Yang
B, Huang
JZ, et al. Sexually transmitted infections among heterosexual male clients of female sex workers in China: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71394. [
PMC free article: PMC3741140] [
PubMed: 23951153]
- 28.
Ong
JJ, Baggaley
RC, Wi
TE, Tucker
JD, Fu
H, Smith
MK, et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV Infection: a systematic review and meta-analysis. JAMA Netw open. 2019;2(12):e1917134. [
PMC free article: PMC6991203] [
PubMed: 31825501]
- 29.
Torrone
EA, Morrison
CS, Chen
PL, Kwok
C, Francis
SC, Hayes
RJ, et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med. 2018;15(2):e1002511. [
PMC free article: PMC5828349] [
PubMed: 29485986]
- 30.
Van Gerwen
OT, Jani
A, Long
DM, Austin
EL, Musgrove
K, Muzny
CA. Prevalence of sexually transmitted infections and human immunodeficiency virus in transgender persons: a systematic review. Transgend Health. 2020;5(2):90–103. [
PMC free article: PMC7347015] [
PubMed: 32656353]
- 31.
Tsuboi
M, Evans
J, Davies
EP, Rowley
J, Korenromp
EL, Clayton
T, et al. Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000–20. Lancet Glob Health. 2021;9(8):e1110–e8. [
PMC free article: PMC9150735] [
PubMed: 34246332]
- 32.
Dumchev
K. Challenges of sexually transmitted infections and sexual health among people who inject drugs. Curr Opin Infect Dis. 2022;35(1):55–60. [
PubMed: 34799511]
- 33.
- 34.
Matthews
GV, Dore
GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol. 2008;23(7pt1):1000–8. [
PubMed: 18707597]
- 35.
- 36.
Platt
L, Easterbrook
P, Gower
E, McDonald
B, Sabin
K, McGowan
C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797–808. [
PubMed: 26922272]
- 37.
Davlidova
S, Haley-Johnson
Z, Nyhan
K, Farooq
A, Vermund
SH, Ali
S. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: a systematic review. Int J Infect Dis. 2021;104:510–25. [
PubMed: 33385583]
- 38.
Cohen
MS, Council
OD, Chen
JS. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. Journal Int AIDS Soc. 2019;22:e25355. [
PMC free article: PMC6715951] [
PubMed: 31468737]
- 39.
Mayer, Kenneth H., and Lao-Tzu
Allan-Blitz. “Similar, but different: drivers of the disproportionate HIV and sexually transmitted infection burden of key populations.” Journal of the International AIDS Society
22, no. Suppl Suppl 6 (2019). [
PMC free article: PMC6716057] [
PubMed: 31468653]
- 40.
Looker
KJ, Elmes
JAR, Gottlieb
SL, Schiffer
JT, Vickerman
P, Turner
KME, et al. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect Dis. 2017;17(12):1303–16. [
PMC free article: PMC5700807] [
PubMed: 28843576]
- 41.
Glynn
JR, Biraro
S, Weiss
HA. Herpes simplex virus type 2: a key role in HIV incidence. AIDS. 2009;23(12):1595–8. [
PubMed: 19512858]
- 42.
Wu
MY, Gong
HZ, Hu
KR, Zheng
HY, Wan
X, Li
J. Effect of syphilis infection on HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2021;97(7):525–33. [
PMC free article: PMC8543214] [
PubMed: 33219164]
- 43.
Massad
LS, Xie
X, Burk
RD, D’Souza
G, Darragh
TM, Minkoff
H, et al. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol. 2016;214(3):354.e1–6. [
PMC free article: PMC4775397] [
PubMed: 26433170]
- 44.
Stelzle
D, Tanaka
LF, Lee
KK, Khalil
AI, Baussano
I, Shah
AS, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161–e9. [
PMC free article: PMC7815633] [
PubMed: 33212031]
- 45.
Global AIDS Strategy 2021–2026. End Inequalities. End AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2021.
- 46.
Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key populations. Geneva: World Health Organization; 2017.
- 47.
Wilson
DP, Donald
B, Shattock
AJ, Wilson
D, Fraser-Hurt
N. The cost-effectiveness of harm reduction. Int J Drug Policy. 2015;26:S5–S11. [
PubMed: 25727260]
- 48.
Cambiano
V, Miners
A, Dunn
D, McCormack
S, Ong
KJ, Gill
ON, et al. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation. Lancet Infect Dis. 2018;18(1):85–94. [
PMC free article: PMC5988036] [
PubMed: 29054789]
- 49.
Gomez
GB, Borquez
A, Case
KK, Wheelock
A, Vassall
A, Hankins
C. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS medicine. 2013;10(3):e1001401. [
PMC free article: PMC3595225] [
PubMed: 23554579]
- 50.
- 51.
United Nations General Assembly. Universal Declaration of Human Rights. United Nations resolution A/RES/217A of 10 December 1948.
- 52.
International Guidelines on HIV/AIDS and Human Rights, (2006). Geneva: Joint United Nations Programme on HIV/AIDS; 2006.
- 53.
International Code of Medical Ethics, (2006). Pilanesberg: World Medical Association; 2006
- 54.
Jamison
DT, Summers
LH, Alleyne
G, Arrow
KJ, Berkley
S, Binagwaho
A, et al. Global health 2035: a world converging within a generation. Lancet. 2013;382(9908):1898–955. [
PubMed: 24309475]
- 55.
The greater involvement of people living with HIV (GIPA): Policy Brief. Geneva: Joint United Nations Programme on HIV/AIDS; 2007.
- 56.
Handbook for guideline development, second edition. Geneva: World Health Organization; 2014.
- 57.
United Nations General Assembly. Universal Declaration of Human Rights. United Nations resolution A/RES/217A of 10 December 1948.
- 58.
United Nations General Assembly. The Vienna Declaration and Programme of Action, June 1993: with the opening statement of United Nations Secretary-General Boutros Boutros-Ghali. United Nations resolution 48/121 of 25 June 1993.
- 59.
United Nations General Assembly. International Covenant on Economic, Social and Cultural Rights. United Nations resolution 2200A of 1966.
- 60.
United Nations General Assembly. International Covenant on Civil and Political Rights. United Nations resolution 2200A of 1966.
- 61.
Evidence for eliminating HIV-related stigma and discrimination — guidance for countries to implement effective programmes to eliminate HIV-related stigma and discrimination in six settings. Geneva: Joint United Nations Programme on HIV/AIDS; 2020.
- 62.
Cichowitz
C, Rubenstein
L, Beyrer
C. Forced anal examinations to ascertain sexual orientation and sexual behavior: an abusive and medically unsound practice. PLoS Med. 2018;15(3):e1002536. [
PMC free article: PMC5856262] [
PubMed: 29547659]
- 63.
Argento
E, Goldenberg
S, Shannon
K. Preventing sexually transmitted and blood borne infections (STBBIs) among sex workers: a critical review of the evidence on determinants and interventions in high-income countries. BMC Infect Dis. 2019;19(1):1–19. [
PMC free article: PMC6399876] [
PubMed: 30832596]
- 64.
Baker
P, Beletsky
L, Avalos
L, Venegas
C, Rivera
C, Strathdee
SA, et al. Policing practices and risk of HIV infection among people who inject drugs. Epidemiol Rev. 2020;42(1):27–40. [
PMC free article: PMC7879596] [
PubMed: 33184637]
- 65.
Bakko
M, Kattari
SK. Transgender-related insurance denials as barriers to transgender healthcare: differences in experience by insurance type. J Gen Intern Med. 2020;35(6):1693–700. [
PMC free article: PMC7280420] [
PubMed: 32128693]
- 66.
DeBeck
K, Cheng
T, Montaner
JS, Beyrer
C, Elliott
R, Sherman
S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357–e74. [
PMC free article: PMC6005363] [
PubMed: 28515014]
- 67.
Hill
BJ, Crosby
R, Bouris
A, Brown
R, Bak
T, Rosentel
K, et al. Exploring transgender legal name change as a potential structural intervention for mitigating social determinants of health among transgender women of color. Sex Res Social Policy. 2018;15(1):25–33. [
PMC free article: PMC5837073] [
PubMed: 29520314]
- 68.
Lyons
CE, Schwartz
SR, Murray
SM, Shannon
K, Diouf
D, Mothopeng
T, et al. The role of sex work laws and stigmas in increasing HIV risks among sex workers. Nat Commun. 2020;11(1):1–10. [
PMC free article: PMC7028952] [
PubMed: 32071298]
- 69.
Millett
GA, Jeffries
WL, Peterson
JL, Malebranche
DJ, Lane
T, Flores
SA, et al. Common roots: a contextual review of HIV epidemics in black men who have sex with men across the African diaspora. Lancet. 2012;380(9839):411–23. [
PubMed: 22819654]
- 70.
Platt
L, Grenfell
P, Meiksin
R, Elmes
J, Sherman
SG, Sanders
T, et al. Associations between sex work laws and sex workers’ health: a systematic review and meta-analysis of quantitative and qualitative studies. PLoS medicine. 2018;15(12):e1002680. [
PMC free article: PMC6289426] [
PubMed: 30532209]
- 71.
Santos
GM, Makofane
K, Arreola
S, Do
T, Ayala
G. Reductions in access to HIV prevention and care services are associated with arrest and convictions in a global survey of men who have sex with men. Sex Transm Infect. 2017;93(1):62–4. [
PubMed: 26944344]
- 72.
Shannon
K, Strathdee
SA, Goldenberg
SM, Duff
P, Mwangi
P, Rusakova
M, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet. 2015;385(9962):55–71. [
PMC free article: PMC4297548] [
PubMed: 25059947]
- 73.
Rich
JD, Hogan
JW, Wolf
F, DeLong
A, Zaller
ND, Mehrotra
M, et al. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend. 2007;89(2–3):292–7. [
PubMed: 17386980]
- 74.
Millett
GA, Peterson
JL, Flores
SA, Hart
TA, Jeffries
WLt, Wilson
PA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012;380(9839):341–8. [
PubMed: 22819656]
- 75.
Platt
L, Grenfell
P, Meiksin
R, Elmes
J, Sherman
SG, Sanders
T, et al. Associations between sex work laws and sex workers’ health: a systematic review and meta-analysis of quantitative and qualitative studies. PLoS Med. 2018;15(12):e1002680. [
PMC free article: PMC6289426] [
PubMed: 30532209]
- 76.
Argento
E, Goldenberg
S, Braschel
M, Machat
S, Strathdee
SA, Shannon
K. The impact of end-demand legislation on sex workers’ access to health and sex worker-led services: a community-based prospective cohort study in Canada. PloS One. 2020;15(4):e0225783. [
PMC free article: PMC7135091] [
PubMed: 32251452]
- 77.
Piot
P, Karim
SSA, Hecht
R, Legido-Quigley
H, Buse
K, Stover
J, et al. Defeating AIDS—advancing global health. Lancet. 2015;386(9989):171–218. [
PubMed: 26117719]
- 78.
Stannah
J, Dale
E, Elmes
J, Staunton
R, Beyrer
C, Mitchell
KM, et al. HIV testing and engagement with the HIV treatment cascade among men who have sex with men in Africa: a systematic review and meta-analysis. Lancet HIV. 2019;6(11):e769–e87. [
PMC free article: PMC6993044] [
PubMed: 31601542]
- 79.
Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people. Geneva: World Health Organization; 2011. [
PubMed: 26158187]
- 80.
- 81.
Key programmes to reduce stigma and discrimination and increase access to justice in national HIV responses: Guidance Note. Geneva: Joint United Nations Programme on HIV/AIDS; 2012.
- 82.
Joint statement on compulsory drug detention and rehabilitation centres. Geneva: Joint United Nations Programme on HIV/AIDS; 2012.
- 83.
Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users – 2012 revision. Geneva: World Health Organization; 2012.
- 84.
Prevention and treatment of HIV and other sexually transmitted infections for sex workers in low and middle-income countries: recommendations for a public health approach. Geneva: World Health Organization; 2012. [
PubMed: 26131541]
- 85.
Effectiveness of interventions to address HIV in prisons. Geneva: World Health Organization; 2007.
- 86.
- 87.
Yam
EA, Pulerwitz
J, Almonte
D, García
F, del Valle
A, Colom
A, et al. Stigma among key populations living with HIV in the Dominican Republic: experiences of people of Haitian descent, MSM, and female sex workers. AIDS. 2020;34:S43–S51. [
PubMed: 32881793]
- 88.
Rogers
S, Tureski
K, Cushnie
A, Brown
A, Bailey
A, Palmer
Q. Layered stigma among health-care and social service providers toward key affected populations in Jamaica and The Bahamas. AIDS Care. 2014;26(5):538–46. [
PubMed: 24125067]
- 89.
Peitzmeier
SM, Grosso
A, Bowes
A, Ceesay
N, Baral
SD. Associations of stigma with negative health outcomes for people living with HIV in the Gambia: implications for key populations. J Acquir Immune Defic Syndr. 2015;68:S146–S53. [
PubMed: 25723979]
- 90.
Lyons
CE, Olawore
O, Turpin
G, Coly
K, Ketende
S, Liestman
B, et al. Intersectional stigmas and HIV-related outcomes among a cohort of key populations enrolled in stigma mitigation interventions in Senegal. AIDS. 2020;34(1):S63. [
PMC free article: PMC7880051] [
PubMed: 32881795]
- 91.
Krishnaratne
S, Bond
V, Stangl
A, Pliakas
T, Mathema
H, Lilleston
P, et al. Stigma and judgment toward people living with HIV and key population groups among three cadres of health workers in South Africa and Zambia: analysis of data from the HPTN 071 (PopART) trial. AIDS Patient Care STDs. 2020;34(1):38–50. [
PMC free article: PMC6983735] [
PubMed: 31944852]
- 92.
Friedland
BA, Sprague
L, Nyblade
L, Baral
SD, Pulerwitz
J, Gottert
A, et al. Measuring intersecting stigma among key populations living with HIV: implementing the people living with HIV Stigma Index 2.0. J Int AIDS Soc. 2018;21(5). [
PMC free article: PMC6055043] [
PubMed: 30033563]
- 93.
Fitzgerald-Husek
A, Van Wert
MJ, Ewing
WF, Grosso
AL, Holland
CE, Katterl
R, et al. Measuring stigma affecting sex workers (SW) and men who have sex with men (MSM): a systematic review. PloS One. 2017;12(11):e0188393. [
PMC free article: PMC5708696] [
PubMed: 29190642]
- 94.
Costa
AB, de Moura Filho
JB, Silva
JM, Beloqui
JA, Espindola
Y, de Araujo
CF, et al. Key and general population HIV-related stigma and discrimination in HIV-specific health care settings: results from the Stigma Index Brazil. AIDS Care. 2021:1–5. [
PubMed: 33487011]
- 95.
- 96.
Stringer
KL, Baker
EH. Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues. 2018;39(1):3–27. [
PMC free article: PMC5754000] [
PubMed: 29307947]
- 97.
Rueda
S, Mitra
S, Chen
S, Gogolishvili
D, Globerman
J, Chambers
L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ open. 2016;6(7):e011453. [
PMC free article: PMC4947735] [
PubMed: 27412106]
- 98.
Hatzenbuehler
ML, O’cleirigh
C, Mayer
KH, Mimiaga
MJ, Safren
SA. Prospective associations between HIV-related stigma, transmission risk behaviors, and adverse mental health outcomes in men who have sex with men. Ann Behav Med. 2011;42(2):227–34. [
PMC free article: PMC3651589] [
PubMed: 21533623]
- 99.
- 100.
Ayhan
CHB, Bilgin
H, Uluman
OT, Sukut
O, Yilmaz
S, Buzlu
S. A systematic review of the discrimination against sexual and gender minority in health care settings. Int J Health Serv. 2020;50(1):44–61. [
PubMed: 31684808]
- 101.
Magno
L, Silva
LAVd, Veras
MA, Pereira-Santos
M, Dourado
I. Stigma and discrimination related to gender identity and vulnerability to HIV/AIDS among transgender women: a systematic review. Cadernos de Saude Publica. 2019;35. [
PubMed: 30994744]
- 102.
Hughto
JMW, Reisner
SL, Pachankis
JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31. [
PMC free article: PMC4689648] [
PubMed: 26599625]
- 103.
Srithanaviboonchai
K, Stockton
M, Pudpong
N, Chariyalertsak
S, Prakongsai
P, Chariyalertsak
C, et al. Building the evidence base for stigma and discrimination-reduction programming in Thailand: development of tools to measure healthcare stigma and discrimination. BMC Public Health. 2017;17(1):1–11. [
PMC free article: PMC5346237] [
PubMed: 28284184]
- 104.
Siegel
J, Yassi
A, Rau
A, Buxton
JA, Wouters
E, Engelbrecht
MC, et al. Workplace interventions to reduce HIV and TB stigma among health care workers – where do we go from here?
Glob Public Health. 2015;10(8):995–1007. [
PubMed: 25769042]
- 105.
Pulerwitz
J, Oanh
KTH, Akinwolemiwa
D, Ashburn
K, Nyblade
L. Improving hospital-based quality of care by reducing HIV-related stigma: evaluation results from Vietnam. AIDS Behav. 2015;19(2):246–56. [
PubMed: 25382350]
- 106.
Odeny
TA, Penner
J, Lewis-Kulzer
J, Leslie
HH, Shade
SB, Adero
W, et al. Integration of HIV care with primary health care services: effect on patient satisfaction and stigma in rural Kenya. AIDS Res Treat. 2013;(7):485715. [
PMC free article: PMC3664481] [
PubMed: 23738055]
- 107.
Mak
WW, Cheng
SS, Law
RW, Cheng
WW, Chan
F. Reducing HIV-related stigma among health-care professionals: a game-based experiential approach. AIDS Care. 2015;27(7):855–9. [
PubMed: 25671591]
- 108.
- 109.
Li
L, Liang
L-J, Wu
Z, Lin
C, Guan
J. Assessing outcomes of a stigma-reduction intervention with venue-based analysis. Soc psychiatry psychiatr Epidemiol. 2014;49(6):991–9. [
PMC free article: PMC4031272] [
PubMed: 24374721]
- 110.
Happell
B, Byrne
L, Platania-Phung
C, Harris
S, Bradshaw
J, Davies
J. Lived-experience participation in nurse education: reducing stigma and enhancing popularity. Int J Ment Health Nurs. 2014;23(5):427–34. [
PubMed: 24898260]
- 111.
Geibel
S, Hossain
SM, Pulerwitz
J, Sultana
N, Hossain
T, Roy
S, et al. Stigma reduction training improves healthcare provider attitudes toward, and experiences of, young marginalized people in Bangladesh. J Adolesc Health. 2017;60(2):S35–S44. [
PubMed: 28109339]
- 112.
Flanagan
EH, Buck
T, Gamble
A, Hunter
C, Sewell
I, Davidson
L. “Recovery speaks”: a photovoice intervention to reduce stigma among primary care providers. Psychiatr Serv. 2016;67(5):566–9. [
PubMed: 26766754]
- 113.
Fernandez
A, Tan
K-A, Knaak
S, Chew
BH, Ghazali
SS. Effects of brief psychoeducational program on stigma in Malaysian pre-clinical medical students: a randomized controlled trial. Acad Psychiatry. 2016;40(6):905–11. [
PubMed: 27527730]
- 114.
Batey
DS, Whitfield
S, Mulla
M, Stringer
KL, Durojaiye
M, McCormick
L, et al. Adaptation and implementation of an intervention to reduce HIV-related stigma among healthcare workers in the United States: piloting of the FRESH workshop. AIDS Patient Care and STDs. 2016;30(11):519–27. [
PMC free article: PMC5116658] [
PubMed: 27849373]
- 115.
Stangl
AL, Lloyd
JK, Brady
LM, Holland
CE, Baral
S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: How far have we come?
J Int AIDS Soc. 2013;16:18734. [
PMC free article: PMC3833106] [
PubMed: 24242268]
- 116.
- 117.
Feyissa
GT, Lockwood
C, Woldie
M, Munn
Z. Reducing HIV-related stigma and discrimination in healthcare settings: a systematic review of guidelines, tools, standards of practice, best practices, consensus statements and systematic reviews. J Multidiscip Healthc. 2018;11:405–16. [
PMC free article: PMC6118284] [
PubMed: 30214222]
- 118.
HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policy makers and managers. Geneva: World Health Organization; 2013. [
PubMed: 25032477]
- 119.
UNAIDS guidance note on HIV and sex work. Geneva: Joint United Nations Programme on HIV/AIDS; 2012.
- 120.
HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policy makers and managers. Geneva: World Health Organization; 2013. [
PubMed: 25032477]
- 121.
Giving young people the information, skills and knowledge they need. Comprehensive sexuality education. New York: United Nations Population Fund; 2013.
- 122.
Wirtz
AL, Pretorius
C, Beyrer
C, Baral
S, Decker
MR, Sherman
SG, et al. Epidemic impacts of a community empowerment intervention for HIV prevention among female sex workers in generalized and concentrated epidemics. PLoS One. 2014;9(2):e88047. [
PMC free article: PMC3916392] [
PubMed: 24516580]
- 123.
- 124.
Platteau
T, van Lankveld
J, Apers
L, Fransen
K, Rockstroh
J, Florence
E. HIV testing for key populations in Europe: a decade of technological innovation and patient empowerment complement the role of health care professionals. HIV Medicine. 2018;19:71–6. [
PubMed: 29488698]
- 125.
Mehrotra
A, Davis
DA, Evens
E, White
B, Wilcher
R. The importance of key population community engagement and empowerment in HIV programming: insights from a global survey with local implementing partners. J Glob Health Reports. 2020;4:e2020044.
- 126.
Laverack
G. Improving health outcomes through community empowerment: a review of the literature. J Health, Popul Nutr. 2006:113–20. [
PubMed: 16796158]
- 127.
Kerrigan
D, Fonner
VA, Stromdahl
S, Kennedy
CE. Community empowerment among female sex workers is an effective HIV prevention intervention: a systematic review of the peer-reviewed evidence from low-and middle-income countries. AIDS Behav. 2013;17(6):1926–40. [
PubMed: 23539185]
- 128.
Kerrigan
D, Mbwambo
J, Likindikoki
S, Davis
W, Mantsios
A, Beckham
SW, et al. Project Shikamana: community empowerment-based combination HIV prevention significantly impacts HIV incidence and care continuum outcomes among female sex workers in Iringa, Tanzania. J Acquir Immune Defic Syndr
2019;82(2):141. [
PMC free article: PMC7393302] [
PubMed: 31513552]
- 129.
Kerrigan
D, Kennedy
CE, Morgan-Thomas
R, Reza-Paul
S, Mwangi
P, Win
KT, et al. A community empowerment approach to the HIV response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up. Lancet. 2015;385(9963):172–85. [
PMC free article: PMC7394498] [
PubMed: 25059938]
- 130.
Kerrigan
D, Donastorg
Y, Barrington
C, Perez
M, Gomez
H, Mbwambo
J, et al. Assessing and addressing social determinants of HIV among female sex workers in the Dominican Republic and Tanzania through community empowerment-based responses. Current HIV/AIDS Reports. 2020;17(2):88–96. [
PMC free article: PMC7144872] [
PubMed: 32072467]
- 131.
Hays
RB, Rebchook
GM, Kegeles
SM. The Mpowerment Project: Community-building with young gay and bisexual men to prevent HIV. Am J Community Psychol. 2003;31(3):301–12. [
PubMed: 12866687]
- 132.
Beckham
SW, Stockton
M, Galai
N, Davis
W, Mwambo
J, Likindikoki
S, et al. Family planning use and correlates among female sex workers in a community empowerment HIV prevention intervention in Iringa, Tanzania: a case for tailored programming. BMC Public Health. 2021;21(1):1–11. [
PMC free article: PMC8274018] [
PubMed: 34247614]
- 133.
Baral
S, Holland
CE, Shannon
K, Logie
C, Semugoma
P, Sithole
B, et al. Enhancing benefits or increasing harms: community responses for HIV among men who have sex with men, transgender women, female sex workers, and people who inject drugs. J Acquir Immune Defic Syndr. 2014;66:S319–S28. [
PubMed: 25007203]
- 134.
Chang
J, Shelly
S, Busz
M, Stoicescu
C, Iryawan
AR, Madybaeva
D, et al. Peer driven or driven peers? A rapid review of peer involvement of people who use drugs in HIV and harm reduction services in low- and middle-income countries. Harm Reduct J. 2021;18(1):15. [
PMC free article: PMC7857348] [
PubMed: 33536033]
- 135.
World Health Organization, United Nations Population Fund, Joint United Nations Programme on HIV/AIDS, Global Network of Sex Work Projects, The World Bank. Implementing comprehensive HIV/STI programmes with sex workers: practical approaches from collaborative interventions. Geneva: World Health Organization; 2013.
- 136.
United Nations Population Fund, Global Forum on MSM & HIV, United Nations Development Programme, World Health Organization, United States Agency for International Development, World Bank. Implementing comprehensive HIV and STI programmes with men who have sex with men: practical guidance for collaborative interventions. New York: United Nations Population Fund; 2015.
- 137.
United Nations Office on Drugs and Crime, International Network of People Who Use Drugs, Joint United Nations Programme on HIV/AIDS, United Nations Development Programme, United Nations Population Fund, World Health Organization, et al. Implementing comprehensive HIV and HCV programmes with people who inject drugs: practical guidance for collaborative interventions. Vienna: United Nations Office on Drugs and Crime; 2017.
- 138.
United Nations Development Programme, IRGT: A Global Network of Transgender Women and HIV, United Nations Population Fund, UCSF Center of Excellence for Transgender Health, Johns Hopkins Bloomberg School of Public Health, World Health Organization, et al. Implementing comprehensive HIV and STI programmes with transgender people: practical guidance for collaborative interventions. New York: United Nations Development Programme; 2016.
- 139.
Establishing community-led monitoring of HIV services. Geneva: Joint United Nations Programme on HIV/AIDS; 2021.
- 140.
Blondeel
K, De Vasconcelos
S, García-Moreno
C, Stephenson
R, Temmerman
M, Toskin
I. Violence motivated by perception of sexual orientation and gender identity: a systematic review. Bull World Health Org. 2018;96(1):29. [
PMC free article: PMC5791869] [
PubMed: 29403098]
- 141.
Sherwood
JA, Grosso
A, Decker
MR, Peitzmeier
S, Papworth
E, Diouf
D, et al. Sexual violence against female sex workers in The Gambia: a cross-sectional examination of the associations between victimization and reproductive, sexual and mental health. BMC Public Health. 2015;15(1):1–10. [
PMC free article: PMC4375842] [
PubMed: 25886187]
- 142.
Nelson
E-UE, Brown
AS. Extra-legal policing strategies and HIV risk environment: accounts of people who inject drugs in Nigeria. Drugs: Educ Prev Policy. 2020;27(4):312–9.
- 143.
Miltz
AR, Lampe
FC, Bacchus
LJ, McCormack
S, Dunn
D, White
E, et al. Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial. BMC Public Health. 2019;19(1):1–17. [
PMC free article: PMC6482482] [
PubMed: 31023281]
- 144.
Griner
SB, Vamos
CA, Thompson
EL, Logan
R, Vázquez-Otero
C, Daley
EM. The intersection of gender identity and violence: victimization experienced by transgender college students. J Interpers Violence. 2020;35(23–24):5704–25. [
PubMed: 29294863]
- 145.
- 146.
Dasgupta
S. Violence in commercial sex work: a case study on the impact of violence among commercial female sex workers in india and strategies to combat violence. Violence Against Women. 2020:1077801220969881. [
PubMed: 33263505]
- 147.
Poteat
T, Ackerman
B, Diouf
D, Ceesay
N, Mothopeng
T, Odette
K-Z, et al. HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis. PLoS medicine. 2017;14(11):e1002422. [
PMC free article: PMC5675306] [
PubMed: 29112689]
- 148.
Smith
LR, Yore
J, Triplett
DP, Urada
L, Nemoto
T, Raj
A. Impact of sexual violence across the lifespan on HIV risk behaviors among transgender women and cisgender people living with HIV. J Acquir Immune Defic Syndr (1999). 2017;75(4):408. [
PMC free article: PMC5810354] [
PubMed: 28653970]
- 149.
Peitzmeier
SM, Malik
M, Kattari
SK, Marrow
E, Stephenson
R, Agénor
M, et al. Intimate partner violence in transgender populations: systematic review and meta-analysis of prevalence and correlates. Am J Public Health. 2020;110(9):e1–e14. [
PMC free article: PMC7427218] [
PubMed: 32673114]
- 150.
- 151.
Lunze
K, Lunze
FI, Raj
A, Samet
JH. Stigma and human rights abuses against people who inject drugs in Russia – a qualitative investigation to inform policy and public health strategies. PloS One. 2015;10(8):e0136030. [
PMC free article: PMC4549320] [
PubMed: 26305697]
- 152.
Lee
JO, Yoon
Y, Idrisov
B, Kiriazova
T, Makarenko
O, Sereda
Y, et al. Violence, HIV risks, and polysubstance use among HIV-positive people who inject drugs in Ukraine. AIDS Behav. 2021;25(7):2120–30. [
PMC free article: PMC9184239] [
PubMed: 33385280]
- 153.
Dunkle
KL, Wong
FY, Nehl
EJ, Lin
L, He
N, Huang
J, et al. Male-on-male intimate partner violence and sexual risk behaviors among money boys and other men who have sex with men in Shanghai, China. Sex Transm Dis. 2013;40(5):362–5. [
PMC free article: PMC8080435] [
PubMed: 23588124]
- 154.
Davis
DA, Morales
GJ, Ridgeway
K, Mendizabal
M, Lanham
M, Dayton
R, et al. The health impacts of violence perpetrated by police, military and other public security forces on gay, bisexual and other men who have sex with men in El Salvador. Cult Health Sex. 2020;22(2):217–32. [
PubMed: 30957697]
- 155.
Sazzad
HM, McCredie
L, Treloar
C, Lloyd
AR, Lafferty
L. Violence and hepatitis C transmission in prison – a modified social ecological model. PloS One. 2020;15(12):e0243106. [
PMC free article: PMC7707477] [
PubMed: 33259565]
- 156.
Russell
M, Chen
M-J, Nochajski
TH, Testa
M, Zimmerman
SJ, Hughes
PS. Risky sexual behavior, bleeding caused by intimate partner violence, and hepatitis C virus infection in patients of a sexually transmitted disease clinic. Am J Public Health. 2009;99(S1):S173–S9. [
PMC free article: PMC2724935] [
PubMed: 19218181]
- 157.
Decker
MR, Wirtz
AL, Baral
SD, Peryshkina
A, Mogilnyi
V, Weber
RA, et al. Injection drug use, sexual risk, violence and STI/HIV among Moscow female sex workers. Sex Transm Infect. 2012;88(4):278–83. [
PMC free article: PMC3628729] [
PubMed: 22287530]
- 158.
Decker
MR, Wirtz
AL, Pretorius
C, Sherman
SG, Sweat
MD, Baral
SD, et al. Estimating the impact of reducing violence against female sex workers on HIV epidemics in Kenya and Ukraine: a policy modeling exercise. Am J Reprod Immunol. 2013;69:122–32. [
PubMed: 23387931]
- 159.
El-Bassel
N, Wechsberg
WM, Shaw
SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS. 2012;7(4):326. [
PMC free article: PMC6330012] [
PubMed: 22498480]
- 160.
Evidence Brief: Violence against women. Intimate partner and sexual violence against women. Geneva: World Health Organization; 2019.
- 161.
Caring for women subjected to violence: a WHO curriculum for training health-care providers. Geneva: World Health Organization; 2019.
- 162.
Responding to intimate partner violence and sexual violence against women: WHO clinical and policy guidelines. Geneva: World Health Organization; 2013. [
PubMed: 24354041]
- 163.
Ando
N, Mizushima
D, Watanabe
K, Takano
M, Shiojiri
D, Uemura
H, et al. Modified self-obtained pooled sampling to screen for
Chlamydia trachomatis and
Neisseria gonorrhoeae infections in men who have sex with men. Sex Transm Infect. 2020;20:20. [
PubMed: 33082236]
- 164.
Handbook on police accountability, oversight and integrity. Vienna: United Nations Office on Drugs and Crime; 2011.
- 165.
Ellsberg
M, Arango
DJ, Morton
M, Gennari
F, Kiplesund
S, Contreras
M, et al. Prevention of violence against women and girls: what does the evidence say?
Lancet. 2015;385(9977):1555–66. [
PubMed: 25467575]
- 166.
Implementation of the joint commitment to effectively addressing and countering the world drug problem with regards to human rights (A/HRC/39/39). UN Human Rights Council; 2018.
- 167.
Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organization; 2004.
- 168.
Guidance on prevention of viral hepatitis B and C among people who inject drugs. Geneva: World Health Organization; 2012. [
PubMed: 23805439]
- 169.
Guidelines for the psyschosocially assisted pharmacological treatment of opioid dependence. Geneva: World Health Organization; 2009. [
PubMed: 23762965]
- 170.
Interventions to address HIV in prions: prevention of sexual transmission. Geneva: World Health Organization; 2007.
- 171.
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring. Geneva: World Health Organization; 2021. [
PubMed: 34370423]
- 172.
Guidelines for long-acting injectable cabotegravir for HIV prevention. Geneva: World Health Organization; 2022. [
PubMed: 36417549]
- 173.
Responding to intimate partner violence and sexual violence against women: WHO clinical and policy guidelines. Geneva: World Health Organization; 2013. [
PubMed: 24354041]
- 174.
WHO guidelines for the treatment of
Treponema pallidum (syphilis)
Geneva: World Health Organization; 2016. [
PubMed: 27631046]
- 175.
Consolidated guidelines on HIV testing services. Geneva: World Health Organization; 2019. [
PubMed: 27977094]
- 176.
Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care. Geneva: World Health Organization; 2019.
- 177.
Guidelines for the Treatment of
Treponema pallidum (syphilis). Geneva: World Health Organization; 2016. [
PubMed: 27631046]
- 178.
Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020. [
PubMed: 32833415]
- 179.
Coomes, David Michael, Dylan
Green, Ruanne
Barnabas, Monisha
Sharma, Magdalena
Barr-Dichiara, Muhammad S.
Jamil, Rachel
Baggaley
et al. “Cost-effectiveness of implementing HIV and HIV/syphilis dual testing among key populations in Viet Nam: a modeling analysis.” medRxiv (2022). [
PMC free article: PMC9379490] [
PubMed: 35953255]
- 180.
Youth-centred digital health interventions: a framework for planning, developing and implementing solutions with and for young people. Geneva: World Health Organization; 2021.
- 181.
WHO information note on the use of dual HIV/syphilis rapid diagnostic tests (RDT). Geneva: World Health Organization; 2017.
- 182.
WHO guideline on self-care interventions for health and well-being. Geneva: World Health Organization; 2021. [
PubMed: 34370426]
- 183.
Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021. [
PubMed: 34370424]
- 184.
Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017.
- 185.
Recommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021. [
PubMed: 34370425]
- 186.
Rodger
AJ, Cambiano
V, Bruun
T, Vernazza
P, Collins
S, Van Lunzen
J, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–81. [
PubMed: 27404185]
- 187.
Cohen
MS, Chen
YQ, McCauley
M, Gamble
T, Hosseinipour
MC, Kumarasamy
N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. [
PMC free article: PMC3200068] [
PubMed: 21767103]
- 188.
Bavinton
BR, Pinto
AN, Phanuphak
N, Grinsztejn
B, Prestage
GP, Zablotska-Manos
IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–e47. [
PubMed: 30025681]
- 189.
WHO consolidated guidelines on tuberculosis: Module 2: Screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2020. [
PubMed: 33822560]
- 190.
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021. Report No. 9240031596. [
PubMed: 34370423]
- 191.
WHO Consolidated guidelines on tuberculosis: Module 4: Treatment - drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020. [
PubMed: 32603040]
- 192.
WHO consolidated guidelines on tuberculosis: Module 1: prevention: tuberculosis preventive treatment. Geneva: World Health Organization; 2020. [
PubMed: 32186832]
- 193.
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018. [
PubMed: 30307724]
- 194.
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015. [
PubMed: 26225396]
- 195.
Grulich
AE, Van Leeuwen
MT, Falster
MO, Vajdic
CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67. [
PubMed: 17617273]
- 196.
World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017;92(19).
- 197.
Medical eligibility criteria for contraceptive use. Geneva: World Health Organization; 2015. [
PubMed: 26447268]
- 198.
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Geneva: World Health Organization; 2021. [
PubMed: 34314129]
- 199.
New WHO recommendations on screening and treatment to prevent cervical cancer among women living with HIV. Geneva: World Health Organization; 2021.
- 200.
Abortion care guideline. Geneva: World Health Organization; 2022. [
PubMed: 35344310]
- 201.
mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: mental health gap action programme (mhGAP). World Health Organization; 2016. [
PubMed: 27786430]
- 202.
- 203.
United Nations General Assembly. Convention on the Rights of the Child. Geneva: 1989.
- 204.
HIV and young people who sell sex: a technical brief. Geneva: World Health Organization; 2015.
- 205.
Rashti
R, Alavian
SM, Moradi
Y, Sharafi
H, Bolbanabad
AM, Roshani
D, et al. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis. Arch Virol. 2020:1–12. [
PubMed: 32617764]
- 206.
Degenhardt
L, Peacock
A, Colledge
S, Leung
J, Grebely
J, Vickerman
P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–e207. [
PMC free article: PMC5683738] [
PubMed: 29074409]
- 207.
Larney
S, Kopinski
H, Beckwith
CG, Zaller
ND, Jarlais
DD, Hagan
H, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013;58(4):1215–24. [
PMC free article: PMC3723697] [
PubMed: 23504650]
- 208.
Larney
S, Peacock
A, Leung
J, Colledge
S, Hickman
M, Vickerman
P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health. 2017;5(12):e1208–e20. [
PMC free article: PMC5683737] [
PubMed: 29074410]
- 209.
Värmå Falk
M, Strömdahl
S, Ekström
AM, Kåberg
M, Karlsson
N, Dahlborn
H, et al. A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs. Harm Reduct J. 2020;17(1):84. [
PMC free article: PMC7579804] [
PubMed: 33092595]
- 210.
DeBeck
K, Cheng
T, Montaner
JS, Beyrer
C, Elliott
R, Sherman
S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357–e74. [
PMC free article: PMC6005363] [
PubMed: 28515014]
- 211.
Grenfell
P, Baptista Leite
R, Garfein
R, de Lussigny
S, Platt
L, Rhodes
T. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature. Drug Alcohol Depend. 2013;129(3):180–209. [
PubMed: 23306095]
- 212.
Getahun
H, Gunneberg
C, Sculier
D, Verster
A, Raviglione
M. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. Curr Opin HIV AIDS. 2012;7(4):345–53. [
PubMed: 22678489]
- 213.
Falla
AM, Hofstraat
SHI, Duffell
E, Hahné
SJM, Tavoschi
L, Veldhuijzen
IK. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC Infect Dis. 2018;18(1):79. [
PMC free article: PMC5809955] [
PubMed: 29433454]
- 214.
Ooi
C, Kong
FYS, Lewis
DA, Hocking
JS. Prevalence of sexually transmissible infections and HIV in men attending sex-on-premises venues in Australia: a systematic review and meta-analysis of observational studies. Sex Health. 2020;17(2):135–48. [
PubMed: 32228828]
- 215.
Beebeejaun
K, Degala
S, Balogun
K, Simms
I, Woodhall
SC, Heinsbroek
E, et al. Outbreak of hepatitis A associated with men who have sex with men (MSM), England, July 2016 to January 2017. Eurosurveillance. 2017;22(5):30454. [
PMC free article: PMC5388117] [
PubMed: 28183392]
- 216.
Chen
G-J, Lin
K-Y, Hung
C-C, Chang
S-C. Hepatitis A outbreak among men who have sex with men in a country of low endemicity of hepatitis A infection. J Infect Dis. 2017;215(8):1339–40. [
PubMed: 28329351]
- 217.
Freidl
GS, Sonder
GJ, Bovée
LP, Friesema
IH, van Rijckevorsel
GG, Ruijs
WL, et al. Hepatitis A outbreak among men who have sex with men (MSM) predominantly linked with the EuroPride, the Netherlands, July 2016 to February 2017. Eurosurveillance. 2017;22(8):30468. [
PMC free article: PMC5356436] [
PubMed: 28251892]
- 218.
Ndumbi
P, Freidl
GS, Williams
CJ, Mårdh
O, Varela
C, Avellón
A, et al. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Eurosurveillance. 2018;23(33):1700641. [
PMC free article: PMC6205254] [
PubMed: 30131095]
- 219.
Werber
D, Michaelis
K, Hausner
M, Sissolak
D, Wenzel
J, Bitzegeio
J, et al. Ongoing outbreaks of hepatitis A among men who have sex with men (MSM), Berlin, November 2016 to January 2017 – linked to other German cities and European countries. Eurosurveillance. 2017;22(5):30457. [
PMC free article: PMC5388120] [
PubMed: 28183391]
- 220.
Asher
AK, Portillo
CJ, Cooper
BA, Dawson-Rose
C, Vlahov
D, Page
KA. Clinicians’ views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs. Subst Use Misuse. 2016;51(9):1218–23. [
PMC free article: PMC6907073] [
PubMed: 27219274]
- 221.
Malekinejad
M, Barker
EK, Merai
R, Lyles
CM, Bernstein
KT, Sipe
TA, et al. Risk of HIV acquisition among men who have sex with men infected with bacterial sexually transmitted infections: a systematic review and meta-analysis. Sex Transm Dis. 2021;48(10):e138–e48. [
PMC free article: PMC8485981] [
PubMed: 33783414]
- 222.
- 223.
Wirtz
AL, Poteat
TC, Malik
M, Glass
N. Gender-based violence against transgender people in the United States: a call for research and programming. Trauma Violence Abuse. 2020;21(2):227–41. [
PubMed: 29439615]
- 224.
Mendes
WG, Silva
C. Homicide of lesbians, gays, bisexuals, travestis, transexuals, and transgender people (LGBT) in Brazil: a spatial analysis. Cien Saude Colet. 2020;25(5):1709–22. [
PubMed: 32402041]
- 225.
- 226.
Rodríguez-Madera
SL, Padilla
M, Varas-Díaz
N, Neilands
T, Vasques Guzzi
AC, Florenciani
EJ, et al. Experiences of violence among transgender women in Puerto Rico: an underestimated problem. J Homosex. 2017;64(2):209–17. [
PMC free article: PMC5546874] [
PubMed: 27054395]
- 227.
Nobili
A, Glazebrook
C, Arcelus
J. Quality of life of treatment-seeking transgender adults: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2018;19(3):199–220. [
PMC free article: PMC6223813] [
PubMed: 30121881]
- 228.
Kelley
J. Stigma and human rights: transgender discrimination and its influence on patient health. Prof Case Manag. 2021;26(6):298–303. [
PubMed: 34609343]
- 229.
Baral
SD, Poteat
T, Strömdahl
S, Wirtz
AL, Guadamuz
TE, Beyrer
C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22. [
PubMed: 23260128]
- 230.
Ghobad
M, Marzieh
S, Roya
R, Hojat
D, Elham
N, Farima
Z, et al. Euro J Med Res. 2021.
- 231.
Van Schuylenbergh
J, Motmans
J, Defreyne
J, Somers
A, T’Sjoen
G. Sexual health, transition-related risk behavior and need for health care among transgender sex workers. Int J Transgend. 2019;20(4):388–402. [
PMC free article: PMC6913627] [
PubMed: 32999624]
- 232.
Wierckx
K, Mueller
S, Weyers
S, Van Caenegem
E, Roef
G, Heylens
G, et al. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med. 2012;9(10):2641–51. [
PubMed: 22906135]
- 233.
Wallace
PM, Rasmussen
S. Analysis of adulterated silicone: implications for health promotion. Int J Transgend. 2010;12(3):167–75.
- 234.
Aguayo-Romero
RA, Reisen
CA, Zea
MC, Bianchi
FT, Poppen
PJ. Gender affirmation and body modification among transgender persons in Bogotá, Colombia. Int J Transgend. 2015;16(2):103–15. [
PMC free article: PMC4733647] [
PubMed: 26839525]
- 235.
Ngoc
M-AT, Greenberg
K, Alio
PA, McIntosh
S, Baldwin
C. Non-medical body modification (body-mod) strategies among transgender and gender diverse (TG/GD) adolescents and young adults. J Adolescent Health. 2020;66(2):S84.
- 236.
International statistical classification of diseases and related health problems (ICD–11). Geneva: World Health Organization; 2019.
- 237.
Prisons and health. Vienna: United Nations Office on Drugs and Crime; 2014.
- 238.
Ahmadi Gharaei
H, Fararouei, M., Mirzazadeh, A.
et al. The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis. Infect Dis Poverty
2021;10:93. [
PMC free article: PMC8252262] [
PubMed: 34210349]
- 239.
Sander
G, Shirley-Beavan
S, Stone
K. The global state of harm reduction in prisons. J Correct Health Care. 2019;25(2):105–20. [
PubMed: 31084277]
- 240.
Fazel
S, Bains
P, Doll
H. Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006;101(2):181–91. [
PubMed: 16445547]
- 241.
Dolan
K, Khoei
EM, Brentari
C, Stevens
A. Prisons and drugs: a global review of incarceration, drug use and drug services. Report 12. 2007.
- 242.
- 243.
The United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules). United Nations Office on Drugs and Crime, Vienna; 2016.
- 244.
Prisons and Health. Denmark: World Health Organization (Europe); 2014.
- 245.
HIV prevention, testing, treatment, care and support in prisons and other closed settings: a comprehensive package of interventions. Vienna: United Nations Office on Drugs and Crime; 2020.
- 246.
HIV/AIDS JUNPo. Progress report of the multistakeholder task team on community-led AIDS responses. Geneva: UNAIDS; 2020.
- 247.
Nguyen
VTT, Phan
HT, Kato
M, Nguyen
QT, Le Ai
KA, Vo
SH, et al. Community-led HIV testing services including HIV self-testing and assisted partner notification services in Vietnam: lessons from a pilot study in a concentrated epidemic setting. J Int AIDS Soc. 2019;22(3):e25301. [
PMC free article: PMC6639698] [
PubMed: 31321903]
- 248.
Vannakit
R, Janyam
S, Linjongrat
D, Chanlearn
P, Sittikarn
S, Pengnonyang
S, et al. Give the community the tools and they will help finish the job: key population-led health services for ending AIDS in Thailand. J Int AIDS Soc. 2020;23(6):e25535. [
PMC free article: PMC7282496] [
PubMed: 32515869]
- 249.
Reza-Paul
S, Lazarus
L, Maiya
R, Venukumar
KT, Lakshmi
B, Roy
A, et al. Delivering community-led integrated HIV and sexual and reproductive health services for sex workers: a mixed methods evaluation of the DIFFER study in Mysore, South India. PLoS One. 2019;14(6):e0218654. [
PMC free article: PMC6588234] [
PubMed: 31226141]
- 250.
Phanuphak
N, Sungsing
T, Jantarapakde
J, Pengnonyang
S, Trachunthong
D, Mingkwanrungruang
P, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health. 2018;15(6):542–55. [
PubMed: 30249317]
- 251.
Onovo
A, Kalaiwo
A, Emmanuel
G, Keiser
O. Community-led index case testing: a promising strategy to improve HIV diagnosis and linkage to care in partners of key populations in Nigeria. Available at SSRN 3872626 (accessed 24 June 2022).
- 252.
Stardust
Z, Kolstee
J, Joksic
S, Gray
J, Hannan
S. A community-led, harm-reduction approach to chemsex: case study from Australia’s largest gay city. Sex Health. 2018;15(2):179–81. [
PubMed: 29592830]
- 253.
Lillie
TA, Persaud
NE, DiCarlo
MC, Gashobotse
D, Kamali
DR, Cheron
M, et al. Reaching the unreached: performance of an enhanced peer outreach approach to identify new HIV cases among female sex workers and men who have sex with men in HIV programs in West and Central Africa. Plos One. 2019;14(4):e0213743. [
PMC free article: PMC6447144] [
PubMed: 30943205]
- 254.
Framework on integrated, people-centred health services. In: Sixty-ninth World Health Assembly, Geneva. Geneva: World Health Organization; 2016.
- 255.
Integrated care models: an overview. Copenhagen: World Health Organization (Europe); 2016.
- 256.
- 257.
Youth-centred digital health interventions: a framework for planning, developing and implementing solutions with and for young people. Geneva: World Health Organization; 2020.
- 258.
Hightow-Weidman
L, Muessig
K, Claude
K, Roberts
J, Zlotorzynska
M, Sanchez
T. Maximizing digital interventions for youth in the midst of covid-19: lessons from the adolescent trials network for HIV interventions. AIDS Behav. 2020;24(8):2239–43. [
PMC free article: PMC7166094] [
PubMed: 32306214]
- 259.
Ames
HM, Glenton
C, Lewin
S, Tamrat
T, Akama
E, Leon
N. Clients’ perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive, maternal, newborn, child, and adolescent health: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2019(10). [
PMC free article: PMC6791116] [
PubMed: 31608981]
- 260.
Inhae
C, Jiwon
K. Effects of mHealth intervention on sexual and reproductive health in emerging adulthood: a systematic review and meta-analysis of randomized controlled trials. Int J Nurs Stud. 2021;119:103949. [
PubMed: 34004469]
- 261.
HIV and young people who sell sex: a technical brief. Geneva: World Health Organization; 2015.
- 262.
HIV and young men who have sex with men. Geneva: World Health Organization; 2015.
- 263.
HIV and young transgender people: a technical brief. Geneva: World Health Organization; 2015.
- 264.
HIV and young people who inject drugs: a technical brief. Geneva: World Health Organization; 2015.
- 265.
- 266.
- 267.
Kteily-Hawa
R, Hawa
AC, Gogolishvili
D, Al Akel
M, Andruszkiewicz
N, Vijayanathan
H, et al. Understanding the epidemiological HIV risk factors and underlying risk context for youth residing in or originating from the Middle East and North Africa (MENA) region: a scoping review of the literature. PloS One. 2022;17(1):e0260935. [
PMC free article: PMC8741013] [
PubMed: 34995320]
- 268.
- 269.
- 270.
Young people and HIV. Geneva: Joint United Nations Programme on HIV/AIDS; 2021.
- 271.
- 272.
Weinstock
HS, Kreisel
KM, Spicknall
IH, Chesson
HW, Miller
WC. STI Prevalence, incidence, and costs in the United States: new estimates, new approach. Sex Transm Dis. 2021;48(4):207. [
PubMed: 33492092]
- 273.
Report on sexually transmitted infections in Canada, 2017. Public Health Agency of Canada; 2019.
- 274.
HIV, viral hepatitis and sexually transmissible infections in Australia – annual surveillance report 2018. Kirby Institute; 2020.
- 275.
Gonorrhoea – Annual epidemiological report for 2018. European Centre for Disease Prevention and Control; 2020.
- 276.
Chlamydia infection – Annual epidemiological report for 2018. European Centre for Disease Prevention and Control; 2020.
- 277.
Bao
Y, Larney
S, Peacock
A, Colledge
S, Grebely
J, Hickman
M, et al. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: a systematic review and meta-analysis. Int J Drug Policy. 2019;70:87–93. [
PMC free article: PMC6679982] [
PubMed: 31125802]
- 278.
Viral Hepatitis Surveillance – United States 2019; Centres for Disease Control and Prevention; May
2021.
- 279.
Degenhardt
L, Peacock
A, Colledge
S, Leung
J, Grebely
J, Vickerman
P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–e207. [
PMC free article: PMC5683738] [
PubMed: 29074409]
- 280.
- 281.
Ie
SI, Turyadi, Sidarta
E, Sadhewa
A, Purnomo
GA, Soedarmono
YS, et al. High prevalence of hepatitis B virus infection in young adults in Ternate, Eastern Indonesia. Am J Trop Med Hyg. 2015;93(6):1349–55. [
PMC free article: PMC4674257] [
PubMed: 26392157]
- 282.
- 283.
Patton
GC, Sawyer
SM, Santelli
JS, Ross
DA, Afifi
R, Allen
NB, et al. Our future: a Lancet commission on adolescent health and wellbeing. Lancet. 2016;387(10036):2423–78. [
PMC free article: PMC5832967] [
PubMed: 27174304]
- 284.
Ramadhani
HO, Crowell
TA, Nowak
RG, Ndembi
N, Kayode
BO, Kokogho
A, et al. Association of age with healthcare needs and engagement among Nigerian men who have sex with men and transgender women: cross-sectional and longitudinal analyses from an observational cohort. J Int AIDS Soc. 2020;23:e25599. [
PMC free article: PMC7527771] [
PubMed: 33000907]
- 285.
Rucinski
KB, Schwartz
SR, Mishra
S, Phaswana-Mafuya
N, Diouf
D, Mothopeng
T, et al. High HIV prevalence and low HIV-service engagement among young women who sell sex: a pooled analysis across 9 Sub-Saharan African countries. J Acquir Immune Defic Syndr. 2020;85(2):148–55. [
PubMed: 32639275]
- 286.
Ninsiima
LR, Chiumia
IK, Ndejjo
R. Factors influencing access to and utilisation of youth-friendly sexual and reproductive health services in sub-Saharan Africa: a systematic review. Reprod Health. 2021;18(1):1–17. [
PMC free article: PMC8237506] [
PubMed: 34176511]
- 287.
Chong
LSH, Kerklaan
J, Clarke
S, Kohn
M, Baumgart
A, Guha
C, Tunnicliffe
DJ, Hanson
CS, Craig
JC, Tong
A. Experiences and Perspectives of Transgender Youths in Accessing Health Care: A Systematic Review. JAMA Pediatr. 2021
Nov
1;175(11):1159–1173. doi: 10.1001/jamapediatrics.2021.2061. PMID: 34279538. [
PubMed: 34279538] [
CrossRef]
- 288.
Assessment of barriers to accessing health services for disadvantaged adolescents in Nigeria. Brazzaville. WHO Regional Office for Africa; 2019.
- 289.
Assessment of barriers to accessing health services for disadvantaged adolescents in Tanzania. Geneva: World Health Organization; 2020.
- 290.
Young people and the law in Asia and the Pacific: a review of laws and policies affecting young people’s access to sexual and reproductive health and HIV services. New York: UNESCO; 2013.
- 291.
Barr-DiChiara
M, Tembo
M, Harrison
L, Quinn
C, Ameyan
W, Sabin
K, et al. Adolescents and age of consent to HIV testing: an updated review of national policies in sub-Saharan Africa. BMJ Open. 2021;11(9):e049673. [
PMC free article: PMC8442095] [
PubMed: 34489284]
- 292.
Robert
K, Maryline
M, Jordan
K, Lina
D, Helgar
M, Annrita
I, et al. Factors influencing access of HIV and sexual and reproductive health services among adolescent key populations in Kenya. Int J Public Health. 2020;65(4):425–32. [
PMC free article: PMC7275021] [
PubMed: 32337631]
- 293.
Shabani
O, Moleki
MM, Thupayagale-Tshweneagae
GG. Individual determinants associated with utilisation of sexual and reproductive health care services for HIV and AIDS prevention by male adolescents. Curationis. 2018;41(1):1–6. [
PMC free article: PMC6111545] [
PubMed: 30198290]
- 294.
Delany-Moretlwe
S, Cowan
FM, Busza
J, Bolton-Moore
C, Kelley
K, Fairlie
L. Providing comprehensive health services for young key populations: needs, barriers and gaps. J Int AIDS Soc. 2015;18:19833. [
PMC free article: PMC4344539] [
PubMed: 25724511]
- 295.
- 296.
Handbook for conducting an adolescent health services barriers assessment (AHSBA) with a focus on disadvantaged adolescents. Geneva: World Health Organization; 2019.
- 297.
World Health Organization, IA Society. A global research agenda for adolescents living with HIV - Research for an AIDS free generation. Geneva: World Health Organization; 2017.
- 298.
Collecting and reporting of sex- and age-disaggregated data on adolescents at the sub-national level
New York City: UNICEF; 2016.
- 299.
United Nations General Assembly. United Nations Convention on the Rights of the Child. United Nations resolution A/Res/44/251989 of 20 November 1989.
- 300.
Global concensus statement: meaningful adolescent and youth engagement. Geneva: World Health Organization; 2020.
- 301.
Global Network of Young People living with HIV (Y+ Global). A guideline for organisations on the meaningful and ethical engagement of young people living with HIV in the HIV response. 2022.
- 302.
Adolescent friendly health services for adolescents living with HIV: from theory to practice, December 2019: a technical brief. Geneva: World Health Organization; 2019.
- 303.
World Health Organization, Joint United Nations Programme on HIV/AIDS. Global standards for quality health-care services for adolescents: a guide to implement a standards-driven approach to improve the quality of health-care services for adolescents. Geneva: World Health Organization; 2015.
- 304.
- 305.
O’Farrell
M, Corcoran
P, Davoren
MP. Examining LGBTI+ inclusive sexual health education from the perspective of both youth and facilitators: a systematic review. BMJ open. 2021;11(9):e047856. [
PMC free article: PMC8413959] [
PubMed: 34475162]
- 306.
What They Don’t Tell You in Sex Ed! – a resource for transgender and gender diverse communities on sexual and reproductive health. Asia Pacific Transgender Network (APTN); 2021.
- 307.
- 308.
READY to Care: improving health services for young people living with HIV. Global Network of Young People Living with HIV; 2019.
- 309.
Young key populations programming guidelines: inspiration for a new era of SRHR and HIV programming for young key populations in Asia-Pacific. Youth LEAD; 2021.
- 310.
Guidelines for healthcare providers on trans-competent healthcare services for transgender patients. Asia Pacific Transgender Network (APTN); 2020.
- 311.
Mark
D, Lovich
R, Walker
D, Burdock
T, Ronan
A, Ameyan
W, et al. Providing peer support for adolescents and young people living with HIV. Geneva: World Health Organization; 2019. Contract No. WHO/CDS/HIV/19.27.
- 312.
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021. Report No. 9240031596. [
PubMed: 34370423]
- 313.
Looking out for adolescents and youth from key populations. UNICEF East Asia & Pacific; 2019.
- 314.
United Nations General Assembly. United Nations guidelines for the alternative care of children. United Nations resolution A/Res/64/142 of 2010.
- 315.
School-based violence prevention: a practical handbook. Geneva: World Health Organization; 2019.
- 316.
INSPIRE handbook: Action for implementing the seven strategies for ending violence against children. Geneva: World Health Organization; 2019.
- 317.
Jones
T, Cornu
C, Liu
Y. Bringing it out in the open: monitoring school violence based on sexual orientation, gender identity or gender expression in national and international surveys. 2019.
- 318.
Embrace diversity and protect trans and gender diverse children and adolescents [press release]. UN Human Rights Office; 16
May
2017.
- 319.
Caring for women subjected to violence: a WHO curriculum for training health-care providers. Geneva: World Health Organization; 2019.
- 320.
Responding to children and adolescents who have been sexually abused. Geneva: World Health Organization; 2017. [
PubMed: 29630189]
- 321.
Reproductive rights and human rights: a handbook for national human rights institutions
Geneva: Office of High Commissioner on Human Rights; 2014.
- 322.
Family planning for adolescents and women at high risk for HIV. Geneva: World Health Organization; 2021.
- 323.
Actions for improved clinical and prevention services and choices: preventing HIV and other sexually transmitted infections among women and girls using contraceptive services in contexts with high HIV incidence. Geneva: World Health Organization; 2020.
- 324.
Laurenzi
CA, du Toit
S, Ameyan
W, Melendez-Torres
G, Kara
T, Brand
A, et al. Psychosocial interventions for improving engagement in care and health and behavioural outcomes for adolescents and young people living with HIV: a systematic review and meta-analysis. J Int AIDS Soc. 2021;24(8):e25741. [
PMC free article: PMC8327356] [
PubMed: 34338417]
- 325.
- 326.
Making every school a health-promoting school – implementation guidance. Geneva: World Health Organization; 2021.
- 327.
The right to housing of LGBT youth: an urgent task in the SDG agenda setting [press release]. Geneva: United Nations Human Rights Council; 2019.
- 328.
Free and equal: LGBTIQ+ Youth Homelessness. Fact sheet. Office of High Commissioner on Human Rights; 2020.
- 329.
Food systems for children and adolescents: working together to secure nutritious diets. New York: UNICEF; 2019.
- 330.
Carducci
B, Oh
C, Roth
DE, Neufeld
LM, Frongillo
EA, L’Abbe
MR, et al. Gaps and priorities in assessment of food environments for children and adolescents in low-and middle-income countries. Nature Food. 2021;2(6):396–403. [
PubMed: 37118231]
- 331.
Transitions from school to work. New York: UNICEF; 2019.
- 332.
Recommended population size estimates of men who have sex with men. Geneva: World Health Organization; 2020.
- 333.
World Health Organization, Joint United Nations Programme on HIV/AIDS. Recommended population size estimates of men who have sex with men. Geneva: World Health Organization; 2020.
- 334.
- 335.
Sterne
JA, Hernán
MA, Reeves
BC, Savović
J, Berkman
ND, Viswanathan
M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. [
PMC free article: PMC5062054] [
PubMed: 27733354]
- 336.
Desrosiers
A, Levy
M, Dright
A, Zumer
M, Jallah
N, Kuo
I, et al. A randomized controlled pilot study of a culturally-tailored counseling intervention to increase uptake of HIV pre-exposure prophylaxis among young black men who have sex with men in Washington, DC. AIDS Behav. 2019;23(1):105–15. [
PMC free article: PMC6344254] [
PubMed: 30171452]
- 337.
DiClemente
RJ, Davis
TL, Swartzendruber
A, Fasula
AM, Boyce
L, Gelaude
D, et al. Efficacy of an HIV/STI sexual risk-reduction intervention for African American adolescent girls in juvenile detention centers: a randomized controlled trial. Women Health. 2014;54(8):726–49. [
PMC free article: PMC4224621] [
PubMed: 25190056]
- 338.
L’Engle
KL, Mwarogo
P, Kingola
N, Sinkele
W, Weiner
DH. A randomized controlled trial of a brief intervention to reduce alcohol use among female sex workers in Mombasa, Kenya. J Acquir Immune Defic Syndr. 2014;67(4):446–53. [
PubMed: 25197826]
- 339.
Hao
C, Huan
X, Yan
H, Yang
H, Guan
W, Xu
X, et al. A randomized controlled trial to evaluate the relative efficacy of enhanced versus standard voluntary counseling and testing on promoting condom use among men who have sex with men in China. AIDS Behav. 2012;16(5):1138–47. [
PubMed: 22298340]
- 340.
El-Bassel
N, Gilbert
L, Wu
E, Witte
SS, Chang
M, Hill
J, et al. Couple-based HIV prevention for low-income drug users from New York City: a randomized controlled trial to reduce dual risks. J Acquir Immune Defic Syndr (1999). 2011;58(2):198. [
PMC free article: PMC5870871] [
PubMed: 21725249]
- 341.
El-Bassel
N, Gilbert
L, Terlikbayeva
A, Beyrer
C, Wu
E, Chang
M, et al. Effects of a couple-based intervention to reduce risks for HIV, HCV, and STIs among drug-involved heterosexual couples in Kazakhstan: a randomized controlled trial. J Acquir Immune Defic Syndr (1999). 2014;67(2):196. [
PMC free article: PMC4162759] [
PubMed: 24991973]
- 342.
El-Bassel
N, Gilbert
L, Goddard-Eckrich
D, Chang
M, Wu
E, Hunt
T, et al. Efficacy of a group-based multimedia HIV prevention intervention for drug-involved women under community supervision: Project WORTH. PloS One. 2014;9(11):e111528. [
PMC free article: PMC4221040] [
PubMed: 25372149]
- 343.
Strathdee
SA, Abramovitz
D, Lozada
R, Martinez
G, Rangel
MG, Vera
A, et al. Reductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trial. PloS One. 2013;8(6):e65812. [
PMC free article: PMC3681783] [
PubMed: 23785451]
- 344.
Eaton
LA, Kalichman
SC, Kalichman
MO, Driffin
DD, Baldwin
R, Zohren
L, et al. Randomised controlled trial of a sexual risk reduction intervention for STI prevention among men who have sex with men in the USA. Sex Transm Infect. 2018;94(1):40–5. [
PubMed: 28404766]
- 345.
Johnson
A, Macgowan
R, Eldridge
G, Morrow
K, Sosman
J, Zack
B, et al. Cost and threshold analysis of an HIV/STI/hepatitis prevention intervention for young men leaving prison: Project START. AIDS Behav. 2013;17(8):2676–84. [
PubMed: 22124581]
- 346.
Burgos
JL, Patterson
TL, Graff-Zivin
JS, Kahn
JG, Rangel
MG, Lozada
MR, et al. Cost-effectiveness of combined sexual and injection risk reduction interventions among female sex workers who inject drugs in two very distinct Mexican border cities. PloS One. 2016;11(2):e0147719. [
PMC free article: PMC4758635] [
PubMed: 26890001]
- 347.
Stephenson
R, Todd
K, Kahle
E, Sullivan
SP, Miller-Perusse
M, Sharma
A, et al. Project Moxie: results of a feasibility study of a telehealth intervention to increase HIV testing among binary and nonbinary transgender youth. AIDS Behav. 2020;24(5):1517–30. [
PMC free article: PMC7162704] [
PubMed: 31760536]
- 348.
Moitra
E, van den Berg
JJ, Sowemimo-Coker
G, Chau
S, Nunn
A, Chan
PA. Open pilot trial of a brief motivational interviewing-based HIV pre-exposure prophylaxis intervention for men who have sex with men: preliminary effects, and evidence of feasibility and acceptability. AIDS Care. 2020
Mar;32(3):406–410. [
PMC free article: PMC6875625] [
PubMed: 31130000]
- 349.
United Nations Independent Expert on protection against violence and discrimination based on sexual orientation and gender identity. Report on conversion therapy. 2020.
- 350.
Velloza
J, Kapogiannis
B, Bekker
L-G, Celum
C, Hosek
S, Delany-Moretlwe
S, et al. Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services?
AIDS. 2021;35(3):463. [
PMC free article: PMC7855564] [
PubMed: 33252486]
- 351.
Schreck
B, Victorri-Vigneau
C, Guerlais
M, Laforgue
E, Grall-Bronnec
M. Slam practice: a review of the literature. European Addiction Research. 2021;27(3):161–78. [
PubMed: 33279895]
- 352.
McCall
H, Adams
N, Mason
D, Willis
J. What is chemsex and why does it matter?
BMJ. 2015
Nov
3;351:h5790. [
PubMed: 26537832]
- 353.
Chemsex and harm reduction for gay men and other men who have sex with men: Briefing Note. London: Harm Reduction International; 2021.
- 354.
Maxwell
S, Shahmanesh
M, Gafos
M. Chemsex behaviours among men who have sex with men: a systematic review of the literature. Int J Drug Policy. 2019;63:74–89. [
PubMed: 30513473]
- 355.
APCOM. A qualitative scoping review of sexualized drug use (including Chemsex) of men who have sex with men and transgender women in Asia.2021.
- 356.
Pakianathan
M, Whittaker
W, Lee
M, Avery
J, Green
S, Nathan
B, et al. Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Med. 2018;19(7):485–90. [
PubMed: 29790254]
- 357.
Pakianathan
M-WW, Lee
MJ, Avery
J,Green
S, Nathan
B,Hegazi
A. Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Med. 2018;19(7):485–90. [
PubMed: 29790254]
- 358.
Tomkins
A, George
R, Kliner
M. Sexualised drug taking among men who have sex with men: a systematic review. Perspect Public Health. 2019;139(1):23–33. [
PubMed: 29846139]
- 359.
Bourne
A, Reid
D, Hickson
F, Torres-Rueda
S, Steinberg
P, Weatherburn
P. “Chemsex” and harm reduction need among gay men in South London. Int J Drug Policy. 2015;26(12):1171–6. [
PubMed: 26298332]
- 360.
Herrijgers
C, Poels
K, Vandebosch
H, Platteau
T, van Lankveld
J, Florence
E. Harm reduction practices and needs in a Belgian chemsex context: findings from a qualitative study. Int J Environ Res Public Health. 2020;17(23):9081. [
PMC free article: PMC7730975] [
PubMed: 33291855]
- 361.
Tomkins
A, Vivancos
R, Ward
C, Kliner
M. How can those engaging in chemsex best be supported? An online survey to gain intelligence in Greater Manchester. Int J STD AIDS. 2018;29(2):128–34. [
PubMed: 28691863]
- 362.
Bedi
A, Sewell
C, Fitzpatrick
C. Peer-led education may be an effective harm reduction strategy for men who have sex with men engaging in ‘chemsex’. Int J STD AIDS. 2020;31(4):392–3. [
PubMed: 32126948]
- 363.
Tan
RKJ, Wong
CM, Mark
I, Chen
C, Chan
YY, Ibrahim
MAB, et al. Chemsex among gay, bisexual, and other men who have sex with men in Singapore and the challenges ahead: a qualitative study. Int J Drug Policy. 2018;61:31–7. [
PubMed: 30388567]
- 364.
Tang
W, Wei
C, Cao
B, Wu
D, Li
KT, Lu
H, et al. Crowdsourcing to expand HIV testing among men who have sex with men in China: a closed cohort stepped wedge cluster randomized controlled trial. PLoS medicine. 2018;15(8):1–19. [
PMC free article: PMC6112627] [
PubMed: 30153265]
- 365.
Zhu
X, Zhang
W, Operario
D, Zhao
Y, Shi
A, Zhang
Z, et al. Effects of a mobile health intervention to promote HIV self-testing with MSM in China: a randomized controlled trial. AIDS Behav. 2019;23(11):3129–39. [
PMC free article: PMC6733671] [
PubMed: 30852728]
- 366.
Lampkin
D, Crawley
A, Lopez
TP, Mejia
CM, Yuen
W, Levy
V. Reaching suburban men who have sex with men for STD and HIV services through online social networking outreach: a public health approach. J Acquir Immune Defic Syndr. 2016;72(1):73–8. [
PubMed: 27097365]
- 367.
Horvath
KJ, Lammert
S, Danh
T, Mitchell
JW. The Feasibility, Acceptability and Preliminary Impact of Mobile Application to Increase Repeat HIV Testing Among Sexual Minority Men. AIDS Behav. 2020
Jun;24(6):1835–1850. [
PubMed: 31823111]
- 368.
Horvath
KJ, Lammert
S, MacLehose
RF, Danh
T, Baker
JV, Carrico
AW. A pilot study of a mobile app to support HIV antiretroviral therapy adherence among men who have sex with men who use stimulants. AIDS Behav. 2019;23(11):3184–98. [
PMC free article: PMC6803067] [
PubMed: 31309348]
- 369.
Kuo
I, Liu
T, Patrick
R, Trezza
C, Bazerman
L, Uhrig Castonguay
BJ, et al. Use of an mHealth intervention to improve engagement in HIV community-based care among persons recently released from a correctional facility in Washington, DC: a pilot study. AIDS Behav. 2019;23(4):1016–31. [
PMC free article: PMC6459706] [
PubMed: 30627850]
- 370.
Songtaweesin
WN, Kawichai
S, Phanuphak
N, Cressey
TR, Wongharn
P, Saisaengjan
C, et al. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020;23(5):e25564. [
PMC free article: PMC7459171] [
PubMed: 32869511]
- 371.
Young
JD, Patel
M, Badowski
M, Mackesy-Amiti
ME, Vaughn
P, Shicker
L, et al. Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: an observational study with historical controls. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2014;59(1):123–6. [
PMC free article: PMC4305134] [
PubMed: 24723283]
- 372.
Arayasirikul
S, Turner
C, Trujillo
D, Le
V, Wilson
EC. Efficacy and impact of digital HIV care navigation in young people living with HIV in San Francisco, California: prospective study. JMIR mHealth and uHealth. 2020;8(5):e18597–e. [
PMC free article: PMC7244993] [
PubMed: 32383680]
- 373.
Brantley
AD, Page
KM, Zack
B, Friedrich
KR, Wendell
D, Robinson
WT, et al. Making the connection: using videoconferencing to increase linkage to care for incarcerated persons living with HIV post-release. AIDS Behav. 2019;23:32–40. [
PubMed: 29680934]
- 374.
Bauermeister
JA, Pingel
ES, Jadwin-Cakmak
L, Harper
GW, Horvath
K, Weiss
G, et al. Acceptability and preliminary efficacy of a tailored online HIV/STI testing intervention for young men who have sex with men: the Get Connected! program. AIDS Behav. 2015;19(10):1860–74. [
PMC free article: PMC4522230] [
PubMed: 25638038]
- 375.
Young
SD, Cumberland
WG, Lee
SJ, Jaganath
D, Szekeres
G, Coates
T. Social networking technologies as an emerging tool for HIV prevention: a cluster randomized trial. Ann Int Med. 2013;159(5):318–24. [
PMC free article: PMC3879120] [
PubMed: 24026317]
- 376.
Ross
C, Shaw
S, Marshall
S, Stephen
S, Bailey
K, Cole
R, et al. Impact of a social media campaign targeting men who have sex with men during an outbreak of syphilis in Winnipeg, Canada. Can Commun Dis Rep. (Releve des maladies transmissibles au Canada). 2016;42(2):45–9. [
PMC free article: PMC5864268] [
PubMed: 29770003]
- 377.
Zhu
X, Zhang
W, Operario
D, Zhao
Y, Shi
A, Zhang
Z, et al. Effects of a mobile health intervention to promote HIV self-testing with MSM in China: a randomized controlled trial. AIDS Behav. 2019;23(11):3129–39. [
PMC free article: PMC6733671] [
PubMed: 30852728]
- 378.
Global strategy on digital health 2020–2025. Geneva: World Health Organization; 2021.
- 379.
Ross
C, Shaw
S, Marshall
S, Stephen
S, Bailey
K, Cole
R, et al. Update on STIs: impact of a social media campaign targeting men who have sex with men during an outbreak of syphilis in Winnipeg, Canada. Canada Commun Dis Rep. 2016;42(2):45. [
PMC free article: PMC5864268] [
PubMed: 29770003]
- 380.
FHI360. Going Online: a budgetting and programming aid for virtual HIV interventions. Durham (NC): FHI360; 2021.
- 381.
Alarcón Gutiérrez
M, Fernández Quevedo
M, Martín Valle
S, Jacques-Aviñó
C, Díez David
E, Caylà
JA, et al. Acceptability and effectiveness of using mobile applications to promote HIV and other STI testing among men who have sex with men in Barcelona, Spain. Sex Transm Infect. 2018;94(6):443–8. [
PubMed: 29626174]
- 382.
Ybarra
M, Nyemara
N, Mugisha
F, Garofalo
R. Opportunities to Harness Technology to Deliver HIV Prevention / Healthy Sexuality Programming to Sexual and Gender Minority Adults Living in East Africa. AIDS Behav. 2021
Apr;25(4):1120–1128. [
PMC free article: PMC10184554] [
PubMed: 33123824]
- 383.
Cao
B, Zhao
P, Bien
C, Pan
S, Tang
W, Watson
J, et al. Linking young men who have sex with men (YMSM) to STI physicians: a nationwide cross-sectional survey in China. BMC Infect Dis. 2018;18(1):1–8. [
PMC free article: PMC5960109] [
PubMed: 29776395]
- 384.
Ventuneac
A, John
SA, Whitfield
THF, Mustanski
B, Parsons
JT. Preferences for sexual health smartphone app features among gay and bisexual men. AIDS Behav. 2018;22(10):3384–94. [
PMC free article: PMC6148366] [
PubMed: 29948335]
- 385.
Fontenot
HB, Rosenberger
JG, McNair
KT, Mayer
KH, Zimet
G. Perspectives and preferences for a mobile health tool designed to facilitate HPV vaccination among young men who have sex with men. Hum Vaccin Immunother. 2019;15(7–8):1815–23. [
PMC free article: PMC6746522] [
PubMed: 30625049]
- 386.
Balán
IC, Lopez-Rios
J, Nayak
S, Lentz
C, Arumugam
S, Kutner
B, et al. SMARTtest: a smartphone app to facilitate HIV and syphilis self- and partner-testing, interpretation of results, and linkage to care. AIDS Behav. 2019;24(5):1560–73. [
PMC free article: PMC7162728] [
PubMed: 31679075]
- 387.
Brennan
DJ, Souleymanov
R, Lachowsky
N, Betancourt
G, Pugh
D, McEwen
O. Providing online-based sexual health outreach to gay, bisexual, and queer men in Ontario, Canada: qualitative interviews with multisectoral frontline service providers and managers. AIDS Patient Care STDs. 2018;32(7):282–7. [
PubMed: 29897787]
- 388.
Fantus
S, Souleymanov
R, Lachowsky
NJ, Brennan
DJ. The emergence of ethical issues in the provision of online sexual health outreach for gay, bisexual, two-spirit and other men who have sex with men: perspectives of online outreach workers. BMC Med Ethics. 2017;18(1):59–70. [
PMC free article: PMC5670555] [
PubMed: 29100520]
- 389.
Recommendations on digital interventions for health system strengthening. Geneva: World Health Organization; 2019. [
PubMed: 31162915]
- 390.
FHI360. A vision for going online to accelerate the impact of HIV programs. Washington DC, USA: FHI360; 2019.
- 391.
Cunningham
WE, Weiss
RE, Nakazono
T, Malek
MA, Shoptaw
SJ, Ettner
SL, et al. Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail: the LINK LA randomized clinical trial. JAMA Intern Med. 2018;178(4):542–53. [
PMC free article: PMC5885257] [
PubMed: 29532059]
- 392.
Reback
CJ, Kisler
KA, Fletcher
JB. A novel adaptation of peer health navigation and contingency management for advancement along the HIV care continuum among transgender women of color. AIDS Behav. 2021;25(1):40–51. [
PMC free article: PMC6904539] [
PubMed: 31187355]
- 393.
Kerrigan
D, Barrington
C, Donastorg
Y, Perez
M, Galai
N. Abriendo Puertas: feasibility and effectiveness a multi-level intervention to improve HIV outcomes among female sex workers living with HIV in the Dominican Republic. AIDS Behav. 2016;20(9):1919–27. [
PubMed: 27016102]
- 394.
Micheni
M, Kombo
BK, Secor
A, Simoni
JM, Operario
D, van der Elst
EM, et al. Health provider views on improving antiretroviral therapy adherence among men who have sex with men in coastal Kenya. AIDS Patient Care STDs. 2017;31(3):113–21. [
PMC free article: PMC5359680] [
PubMed: 28282249]
- 395.
Pitpitan
EV, Mittal
ML, Smith
LR. Perceived need and acceptability of a community-based peer navigator model to engage key populations in HIV care in Tijuana, Mexico. J Int Assoc Provid AIDS Care (JIAPAC). 2020;19:2325958220919276. [
PMC free article: PMC7175050] [
PubMed: 32314646]
- 396.
Guidelines for the screening, care and treatment of persons with chronic Hepatitis C Infection. Geneva: World Health Organization; 2016. [
PubMed: 27227200]
- 397.
Grebely
J, Page
K, Sacks-Davis
R, van der Loeff
MS, Rice
TM, Bruneau
J, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59(1):109–20. [
PMC free article: PMC3972017] [
PubMed: 23908124]
- 398.
Hellard
M, Sacks-Davis
R, Doyle
J. Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks. J Epidemiol Community Health. 2016;70(12):1151–4. [
PubMed: 27343304]
- 399.
Falade-Nwulia
O, Sulkowski
MS, Merkow
A, Latkin
C, Mehta
SH. Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era. J Viral Hepat. 2018;25(3):220–7. [
PMC free article: PMC5841922] [
PubMed: 29316030]
- 400.
EASL recommendations on treatment of hepatitis C: final update of the series(☆). J Hepatol. 2020;73(5):1170–218. [
PubMed: 32956768]
- 401.
Chaillon
A, Mehta
SR, Hoenigl
M, Solomon
SS, Vickerman
P, Hickman
M, et al. Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection. PloS One. 2019;14(6):e0217964. [
PMC free article: PMC6553784] [
PubMed: 31170246]
- 402.
Castry
M, Cousien
A, Supervie
V, Velter
A, Ghosn
J, Paltiel
AD, Yazdanpanah
Y, Deuffic-Burban
S. Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach. Gut. 2020
Oct
27:gutjnl-2020-321744. [
PubMed: 33109688]
- 403.
Castry
M, Cousien
A, Supervie
V, Velter
A, Ghosn
J, Paltiel
AD, et al. Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach. Gut. 2021;70(8):1561–9. [
PubMed: 33109688]
- 404.
Martinello
M, Orkin
C, Cooke
G, Bhagani
S, Gane
E, Kulasegaram
R, et al. Short-duration pan-genotypic therapy with glecaprevir/pibrentasvir for 6 weeks among people with recent hepatitis C viral infection. Hepatology. 2020;72(1):7–18. [
PubMed: 31652357]
- 405.
Pawlotsky
J-M, Negro
F, Aghemo
A, Berenguer
M, Dalgard
O, Dusheiko
G, et al. EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol. 2020;73(5):1170–218. [
PubMed: 32956768]
- 406.
Ghany
MG, Morgan
TR, panel AIhCg. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America: Recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686–721. [
PMC free article: PMC9710295] [
PubMed: 31816111]
- 407.
Gómez-Ayerbe
C, Palacios
R, Ríos
MJ, Téllez
F, Sayago
C, Martín-Aspas
A, et al. Acute hepatitis C virus infection and direct-acting antiviral drugs: perfect combination to eliminate the epidemic?
Int J STD & AIDS. 2021:09564624211033756. [
PubMed: 34293985]
- 408.
Boesecke
C, Nelson
M, Ingiliz
P, Lutz
T, Scholten
S, Cordes
C, et al., editors. Can’t buy me love? Obstacles to microelimination of acute HCV coinfection in Europe. In: Twenty-sixth conference on retroviruses and opportunistic infections; 2019.
- 409.
Chromy
D, Mandorfer
M, Bucsics
T, Schwabl
P, Scheiner
B, Schmidbauer
C, et al. High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients. United Eur Gastroenterol J. 2019;7(4):507–16. [
PMC free article: PMC6488804] [
PubMed: 31065368]
- 410.
Cannon
L, Dhillon
R, A
T, Teo
S, Garner
A, Ward
C, et al. Hepatitis C infection and treatment outcomes in the DAA era. HIV Med. 2020;21:51.
- 411.
Cotte
L, Hocqueloux
L, Lefebvre
M, Pradat
P, Bani-Sadr
F, Huleux
T, Poizot-Martin
I, Pugliese
P, Rey
D, Cabié A; Dat’AIDS Study Group. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018. Clin Infect Dis. 2021
Nov
2;73(9):e3266–e3274. [
PubMed: 33400777]
- 412.
Garvey
LJ, Cooke
GS, Smith
C, Stingone
C, Ghosh
I, Dakshina
S, et al. Decline in hepatitis C virus (HCV) incidence in men who have sex with men living with human immunodeficiency virus: progress to HCV microelimination in the United Kingdom?
Clin Infect Dis. 2020;72(2):233–8. [
PMC free article: PMC7840101] [
PubMed: 32211763]
- 413.
Girometti
N, Devitt
E, Phillips
J, Nelson
M, Whitlock
G. High rates of unprotected anal sex and use of generic direct-acting antivirals in a cohort of MSM with acute HCV infection. J Viral Hepat. 2019;26(6):627–34. [
PubMed: 30661272]
- 414.
Huang
MH, Chang
SY, Liu
CH, Cheng
A, Su
LH, Liu
WC, et al. HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan. Liver Int. 2019;39(10):1860–7. [
PubMed: 31343813]
- 415.
Naggie
S, Fierer
DS, Hughes
MD, Kim
AY, Luetkemeyer
A, Vu
V, et al. Ledipasvir/sofosbuvir for 8 weeks to treat acute hepatitis C virus infections in men with human immunodeficiency virus infections: sofosbuvir-containing regimens without interferon for treatment of acute HCV in HIV-1 infected individuals. Clin Infect Dis. 2019;69(3):514–22. [
PMC free article: PMC6637278] [
PubMed: 31220220]
- 416.
Braun
DL, Hampel
B, Ledergerber
B, Grube
C, Nguyen
H, Künzler-Heule
P, et al. A treatment-as-prevention trial to eliminate hepatitis C among men who have sex with men living with human immunodeficiency virus (HIV) in the Swiss HIV cohort study. Clin Infect Dis. 2021;73(7):e2194–e202. [
PubMed: 32761122]
- 417.
Matthews
GV, Bhagani
S, Van der Valk
M, Rockstroh
J, Feld
JJ, Rauch
A, Thurnheer
C, Bruneau
J, Kim
A, Hellard
M, Shaw
D, Gane
E, Nelson
M, Ingiliz
P, Applegate
TL, Grebely
J, Marks
P, Martinello
M, Petoumenos
K, Dore
GJ; REACT study group; Protocol Steering Committee; Coordinating Centre; Site Principal Investigators. Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. J Hepatol. 2021
Oct;75(4):829–839. [
PMC free article: PMC9831671] [
PubMed: 34023350]
- 418.
Latham
NH, Doyle
JS, Palmer
AY, Vanhommerig
JW, Agius
P, Goutzamanis
S, et al. Staying hepatitis C negative: a systematic review and meta-analysis of cure and reinfection in people who inject drugs. 2019;39(12):2244–60. [
PubMed: 31125496]
- 419.
Palaniswami
PM, El Sayed
A, Asriel
B, Carollo
JR, Fierer
DS, editors. Ledipasvir and sofosbuvir in the treatment of early hepatitis C virus infection in HIV-infected men. Open Forum Infect Dis. 2018; Oxford University Press
US. [
PMC free article: PMC6189631] [
PubMed: 30349848]
- 420.
Bethea
ED, Chen
Q, Hur
C, Chung
RT, Chhatwal
J. Should we treat acute hepatitis C? A decision and costeffectiveness analysis. Hepatology (Baltimore, Md). 2018;67(3):837–46. [
PMC free article: PMC5826841] [
PubMed: 29059461]
- 421.
Liu
Y, Zhang
H, Zhang
L, Zou
X, Ling
L. Economic evaluation of hepatitis C treatment extension to acute infection and early-stage fibrosis among patients who inject drugs in developing countries: a case of China. Int J Environm Res Public Health. 2020;17(3). [
PMC free article: PMC7037788] [
PubMed: 32012839]
- 422.
Mukherjee
S, Colby
D, Ramautarsing
R, Popping
S, Sriplienchan
S, Chinbunchorn
T, et al. Expanding reimbursement of immediate treatment using direct acting antivirals to reduce hepatitis C incidence among HIV positive men who have sex with men in Bangkok, Thailand: a cost effectiveness modelling study. J Virus Erad. 2021;7(2):100042. [
PMC free article: PMC8184647] [
PubMed: 34141441]
- 423.
Popping
S, Hullegie
SJ, Boerekamps
A, Rijnders
BJA, de Knegt
RJ, Rockstroh
JK, et al. Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men. PLoS One. 2019;14(1):e0210179. [
PMC free article: PMC6328146] [
PubMed: 30629662]
- 424.
- 425.
Unemo
M, Jensen
JS. Antimicrobial-resistant sexually transmitted infections: gonorrhoea and
Mycoplasma genitalium. Nat Rev Urol. 2017;14(3):139–52. [
PubMed: 28072403]
- 426.
Cristillo
AD, Bristow
CC, Torrone
E, Dillon
JA, Kirkcaldy
RD, Dong
H, et al. Antimicrobial resistance in
Neisseria Gonorrhoeae: proceedings of the STAR sexually transmitted infection-clinical trial group programmatic meeting. Sex Transm Dis. 2019;46(3):e18–e25. [
PMC free article: PMC6370498] [
PubMed: 30363025]
- 427.
Barbee
LA, Dombrowski
JC, Kerani
R, Golden
MR. Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients. Sex Transm Dis. 2014;41(3):168–72. [
PubMed: 24521722]
- 428.
van Liere
GA, van Rooijen
MS, Hoebe
CJ, Heijman
T, de Vries
HJ, Dukers-Muijrers
NH. Prevalence of and factors associated with rectal-only chlamydia and gonorrhoea in women and in men who have sex with men. PLoS One. 2015;10(10):e0140297. [
PMC free article: PMC4626043] [
PubMed: 26513479]
- 429.
Gunn
RA, O’Brien
CJ, Lee
MA, Gilchick
RA. Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997–2003. Sex Transm Dis. 2008;35(10):845–8. [
PubMed: 18607315]
- 430.
Wi
TE, Ndowa
FJ, Ferreyra
C, Kelly-Cirino
C, Taylor
MM, Toskin
I, et al. Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward. J Int AIDS Soc. 2019;22(S6):e25343. [
PMC free article: PMC6715950] [
PubMed: 31468679]
- 431.
Aboud
L, Xu
Y, Chow
EP, Wi
T, Baggaley
R, Mello
MB, et al. Diagnostic accuracy of pooling urine, anorectal, and orooropharyngeal specimens for the detection of
Chlamydia trachomatis and
Neisseria gonorrhoeae: a systematic review and meta-analysis. BMC Med. 2021;19(1):1–11. [
PMC free article: PMC8614052] [
PubMed: 34819068]
- 432.
Thammajaruk
N, Promthong
S, Posita
P, Chumseng
S, Nampaisan
O, Srivachiraroj
P, et al. Pooled oropharyngeal, rectal and urine samples for the point-of-care detection of Chlamydia trachomatis and Neisseria gonorrhoeae by lay-providers in key population-led health services in Thailand. J Int Aids Soc. 2020;23:115–6.
- 433.
Sultan
B, White
JA, Fish
R, Carrick
G, Brima
N, Copas
A, et al. The “3 in 1” study: pooling self-taken oropharyngeal, urethral, and rectal samples into a single sample for analysis for detection of
Neisseria gonorrhoeae and
Chlamydia trachomatis in men who have sex with men. J Clin Microbiol. 2016;54(3):650–6. [
PMC free article: PMC4767962] [
PubMed: 26719439]
- 434.
Dean
JA, Bell
SFE, Coffey
L, Debattista
J, Badman
S, Redmond
AM, et al. Improved sensitivity from pooled urine, oropharyngeal and rectal specimens when using a molecular assay for the detection of chlamydia and gonorrhoea near point of care. Sex Transm Infect. 2020;13:13. [
PubMed: 33188137]
- 435.
Badman
SG, Bell
SFE, Dean
JA, Lemoire
J, Coffey
L, Debattista
J, et al. Reduced sensitivity from pooled urine, oropharyngeal and rectal specimens when using a molecular assay for the detection of chlamydia and gonorrhoea near the point of care. Sex Health. 2020;17(1):15–21. [
PubMed: 31945307]
- 436.
Verougstraete
N, Verbeke
V, De Canniere
AS, Simons
C, Padalko
E, Coorevits
L. To pool or not to pool? Screening of
Chlamydia trachomatis and
Neisseria gonorrhoeae in female sex workers: pooled versus single-site testing. Sex Transm Infect. 2020;96(6):417–21. [
PubMed: 32404400]
- 437.
De Baetselier
I, Vuylsteke
B, Yaya
I, Dagnra
A, Diande
S, Mensah
E, et al. To pool or not to pool samples for sexually transmitted infections detection in men who have sex with men? An evaluation of a new pooling method using the genexpert instrument in West Africa. Sex Transm Dis. 2020;47(8):556–61. [
PubMed: 32355106]
- 438.
Wilson
JD, Wallace
HE, Loftus-Keeling
M, Ward
H, Davies
B, Vargas-Palacios
A, et al. Swab-yourself trial with economic monitoring and testing for infections collectively (SYSTEMATIC): Part 2. A diagnostic accuracy, and cost-effectiveness, study comparing rectal, oropharyngeal and urogenital samples analysed individually, versus as a pooled specimen, for the diagnosis of gonorrhoea and chlamydia. Clin Infect Dis. 2020;12:12. [
PubMed: 33044490]
- 439.
Chernesky
M, Jang
D, Martin
I, Arias
M, Shah
A, Smieja
M, et al.
Mycoplasma genitalium,
Chlamydia trachomatis, and
Neisseria gonorrhoeae detected with aptima assays performed on self-obtained vaginal swabs and urine collected at home and in a clinic. Sex Transm Dis. 2019;46(9):e87–e9. [
PubMed: 31415336]
- 440.
Speers
DJ, Chua
IJ, Manuel
J, Marshall
L. Detection of
Neisseria gonorrhoeae and
Chlamydia trachomatis from pooled rectal, oropharyngeal and urine specimens in men who have sex with men. Sex Transm Infect. 2018;94(4):293–7. [
PubMed: 29066627]
- 441.
Shaw
J, Saunders
JM, Hughes
G. Attitudes to, and experience of, pooled sampling for sexually transmitted infection testing: a web-based survey of English sexual health services. Int J STD AIDS. 2018;29(6):547–51. [
PubMed: 29157170]
- 442.
De Baetselier
I, Osbak
KK, Smet
H, Kenyon
CR, Crucitti
T. Take three, test one: a cross-sectional study to evaluate the molecular detection of
Chlamydia trachomatis and
Neisseria gonorrhoeae in pooled oropharyngeal, anorectal and urine samples versus single-site testing among men who have sex with men in Belgium. Acta Clinica Belgica. 2020;75(2):91–5. [
PubMed: 30415606]
- 443.
Guidelines for the Treatment of
Chlamydia trachomatis. Geneva: World Health Organization; 2016. [
PubMed: 27559553]
- 444.
Guidelines for the treatment of
Neisseria gonorrhoeae. Geneva: World Health Organization; 2016. [
PubMed: 27512795]